Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

June 30, 2022 by Elise Morrison 3 min read

EHA 2022 & EACR 2022: Europe is back in-person

After a long period of virtual shows, we had the pleasure of being part of two great conferences in Europe: the EHA2022 Hybrid Congress June 9-12, 2022 in Vienna and the EACR 2022 June 20-24, 2022 in Seville.

First of all, it was great to see people back in person, listening to and participating in scientific conversations and also being able to socialize and network again. Read on to hear some highlights during our tour of Europe!

The EHA2022 Hybrid Congress in Vienna covered a wide range of hematologic related topics – from acute leukemia, over chronic lymphoid and myeloid malignancies, to lymphomas, red & white cell disorders and thrombosis & hemostasis.

A highlight was the presentation of Dr. Ferran Nadeau “Genomic heterogeneity in indolent lymphoma” in the Lymphoid Biology and Malignancy Workshop – Session 3: Genetic heterogeneity in lymphoma biology. Dr. Nadeau presented Chronic lymphocytic leukemia (CLL) transformation to Richter Syndrome. The patients in this study were diagnosed with CLL up to 19 years before the transformation. For one specific patient, they were able to detect the clone 14 years before transformation where the expansion happens upon treatment with Ibrutinib .

We were very happy to welcome our Chief Medical Officer, Todd Druley, MD, PhD and Sr. Director, Clinical Applications, Aaron Llanso in Vienna. They shared the latest advancements in single-cell DNA sequencing, particularly in the field of single-cell Minimal Residual Disease (scMRD), Clonal Hematopoiesis, and Therapeutic Resistance during our event at the historic Wiener Rathauskeller on June 11th. After their presentation, we had a great time with Viennese wine and food and scientific discussions with our guests there.

Just a few days later we were on our way to beautiful Seville to attend EACR 2022!

This four-day congress was dedicated to basic, preclinical and translational cancer research across a wide breadth of topics – bringing together the cancer research community to inspire innovation and build knowledge, connections and collaborations.

We enjoyed inspiring scientific communications at our booth and the bustling poster session. Our colleagues Aik Ooi, Senior Staff Scientist, and Prithvi Singh, Research Associate, were on hand to present our poster “Multimodal Analysis of DNA and Proteins in Single Cells

Another highlight from the poster presentation was the poster “Using Single Cell Multi-omics to Characterize Cancer” from our new Center of Excellence in Europe – the Josep Carreras Leukaemia Research Institute. They presented beautiful fish plots from a study with patient samples on myelodysplastic syndrome (MDS). The goal of this study is to improve MDS treatments and reveal details about this very heterogeneous disease.

As a grand finale to EACR 2022, we were happy to welcome scientists from all over the world for a Mission Bio social event on Wednesday evening. On the scenic rooftop terrace of the Hotel Doña María with a fantastic view over the Seville Cathedral, we enjoyed Andalusian cuisine, drinks, and scientific discussions.

It was fantastic to see our colleagues, fellow scientists, and attendees in-person again. Curious where the Mission Bio team will be heading next? Get our full Events schedule here.

June 13, 2024
Translocation Analysis Offers Insights for Gene-Edited Cell Safety
April 17, 2024
Publication Highlight: Clonal dominance defines metastatic dissemination in pancreatic cancer
March 21, 2024
Looking Forward: The Potential of Single-cell to Accelerate Clinical Research & Development
February 29, 2024
CRISPR-edited gene pools: Exploring variation in gene-edited cells